TGF-β may induce mesenchymal transformation to enhance cancer cells’ invasion and metastasis; however, the exact mechanism remains to be entirely determined.[43,44] After patients receive RT, both anti- and pro-inflammatory factors dynamically change with cytokines interacting with the tumor microenvironment in a complex cytokine network. Here, TGFB1 is linked to cancer.